HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

palbociclib

has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6; structure in first source
Also Known As:
6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one; Ibrance; PD 0332991; PD-0332991; PD0332991
Networked: 1222 relevant articles (200 outcomes, 344 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cristofanilli, Massimo: 25 articles (06/2022 - 07/2015)
2. Finn, Richard S: 23 articles (01/2021 - 01/2009)
3. Turner, Nicholas C: 22 articles (01/2022 - 07/2015)
4. Rugo, Hope S: 21 articles (01/2022 - 01/2016)
5. Iwata, Hiroji: 20 articles (10/2022 - 07/2015)
6. Huang, Xin: 19 articles (01/2022 - 01/2015)
7. Im, Seock-Ah: 17 articles (04/2022 - 04/2016)
8. Masuda, Norikazu: 17 articles (01/2022 - 04/2016)
9. Harbeck, Nadia: 16 articles (01/2022 - 07/2015)
10. Slamon, Dennis J: 16 articles (01/2022 - 01/2009)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Disease Progression
5. Squamous Cell Carcinoma of Head and Neck

Related Drugs and Biologics

1. Letrozole (Femara)
2. Hormones (Hormone)
3. Fulvestrant (Faslodex)
4. ribociclib
5. ErbB Receptors (EGF Receptor)
6. Estrogen Receptors
7. abemaciclib
8. Cyclin-Dependent Kinases (cdk Proteins)
9. Cyclin-Dependent Kinase 4
10. Aromatase Inhibitors

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiotherapy
4. Oral Administration
5. TP protocol